Masato Tamari, Kate L Del Bel, Aaron M Ver Heul, Lydia Zamidar, Keisuke Orimo, Masato Hoshi, Anna M Trier, Hiroshi Yano, Ting-Lin Yang, Catherine M Biggs, Kenichiro Motomura, Rintaro Shibuya, Chuyue D Yu, Zili Xie, Hisato Iriki, Zhen Wang, Kelsey Auyeung, Gargi Damle, Deniz Demircioglu, Jill K Gregory, Dan Hasson, Jinye Dai, Rui B Chang, Hideaki Morita, Kenji Matsumoto, Sanjay Jain, Steven Van Dyken, Joshua D Milner, Dusan Bogunovic, Hongzhen Hu, David Artis, Stuart E Turvey, Brian S Kim
Cytokines employ downstream Janus kinases (JAKs) to promote chronic inflammatory diseases. JAK1-dependent type 2 cytokines drive allergic inflammation, and patients with JAK1 gain-of-function (GoF) variants develop atopic dermatitis (AD) and asthma. To explore tissue-specific functions, we inserted a human JAK1 GoF variant (JAK1GoF ) into mice and observed the development of spontaneous AD-like skin disease but unexpected resistance to lung inflammation when JAK1GoF expression was restricted to the stroma. We identified a previously unrecognized role for JAK1 in vagal sensory neurons in suppressing airway inflammation...
January 4, 2024: Cell